Per Hove Thomsen

Off-label brug af psykofarmaka til børn og unge i Danmark

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Anne Katrine Pagsberg, Forskningsenheden ved Børne- og Ungdomspsykiatrisk Center i Region Hovedstadens Psykiatri, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet, Danmark
  • Per Hove Thomsen

Despite regulatory initiatives, psychopharmacological treatment of adolescents is challenged by missing trial data on efficacy and safety. In Denmark, an estimated mean off-label prescription rate of 30-40% in clinical child- and adolescent mental health services has been found in recent studies. The lowest rates were found for drugs treating ADHD (2-3%), and the highest for antipsychotics (96%) and melatonin (100%). The use of melatonin is growing, while the use of other psychopharmacological drugs appears to be stabilizing or decreasing, in spite of an increased number of adolescents treated in Danish mental health services.

OriginalsprogDansk
ArtikelnummerV05170355
TidsskriftUgeskrift for Laeger
Vol/bind179
Nummer35
Sider (fra-til)2-6
Antal sider5
ISSN0041-5782
StatusUdgivet - 28 aug. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 117642010